From Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M:

Exosome Diagnostics Logo
Exosome Diagnostics Logo

Cambridge, MA-based Exosome Diagnostics is developing fluid-based tests for cancer.